Livzon Pharmaceutical Group Inc

Common Name
Livzon Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,067
Ticker
000513
Exchange
SHENZHEN STOCK EXCHANGE
Description
Livzon Pharmaceutical Group Inc. is a prominent healthcare entity specializing in the research, development, production, and distribution of pharmaceutical products. Its primary function is to improve...

Livzon Pharmaceutical Group's GHG Emissions Data Preview

In 2024, Livzon Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Livzon Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Livzon Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Livzon Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.

a. Livzon Pharmaceutical Group's ESG Report 2024
a. Livzon Pharmaceutical Group's ESG Report 2024
b. Livzon Pharmaceutical Group's ESG Report 2022
b. Livzon Pharmaceutical Group's ESG Report 2022

Insights into Livzon Pharmaceutical Group's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Livzon Pharmaceutical Group amounted to 521,159.37 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Livzon Pharmaceutical Group increased by 1.33%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Livzon Pharmaceutical Group's Scope 1 Emissions Over Time

20202021202220232024050 k100 k150 k200 ktCO2e+535%+2%-21%+25%
  • Total Scope 1
  • Year-over-Year Change

What are Livzon Pharmaceutical Group's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Livzon Pharmaceutical Group were 194,440.58 metric tons of CO₂ equivalent (tCO₂e). a

Has Livzon Pharmaceutical Group reduced its Scope 1 emissions over time?

Since 2020, Livzon Pharmaceutical Group's Scope 1 emissions have increased by 539.02%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), Livzon Pharmaceutical Group's Scope 1 emissions increased by 24.8%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Livzon Pharmaceutical Group's Scope 2 emissions?

In 2024, Livzon Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 326,718.79 tCO₂e without specifying the calculation method. a

Has Livzon Pharmaceutical Group reduced its Scope 2 emissions over time?

Since 2020, Livzon Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 39.94%, reflecting a declining long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2023), Livzon Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Livzon Pharmaceutical Group 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Livzon Pharmaceutical Group use for Scope 2 reporting?

In 2024, Livzon Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology. a

Livzon Pharmaceutical Group's Scope 2 Emissions Over Time

202020212022202320240150 k300 k450 k600 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Livzon Pharmaceutical Group's Value Chain Emissions

In 2024, Livzon Pharmaceutical Group reported 1,709,496.18 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Livzon Pharmaceutical Group includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Livzon Pharmaceutical Group's Scope 3 Emissions Over Time

20240450 k900 k1.35 M1.8 MtCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Livzon Pharmaceutical Group's Scope 3 emissions?

In 2024, Livzon Pharmaceutical Group reported total Scope 3 emissions of 1,709,496.18 metric tons of CO₂ equivalent (tCO₂e). a

Insights into Livzon Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Livzon Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 194,440.58 tCO₂e and total revenues of USD 1,619 millions. This translates into an emissions intensity of 120.13 tCO₂e per millions USD. a

Livzon Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers

1020010,000200,00010,000,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CCHPDSDCCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$M

How does Livzon Pharmaceutical Group's GHG emissions intensity compare to its peers?

In 2024, Livzon Pharmaceutical Group reported a Scope 1 emissions intensity of 120.13 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Livzon Pharmaceutical Group rank on GHG emissions intensity within its industry?

In 2024, Livzon Pharmaceutical Group ranked 23 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Livzon Pharmaceutical Group among the least efficient performers, with one of the highest emissions intensities in its sector. a

Insights into Livzon Pharmaceutical Group's Total Carbon Footprint

In 2024, Livzon Pharmaceutical Group reported a total carbon footprint of 2,230,655.55 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 333.7% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Livzon Pharmaceutical Group's total carbon footprint was Scope 3 emissions, accounting for 76.64% of the company's total carbon footprint, followed by Scope 2 emissions at 14.65%. a

Want Full Access to Livzon Pharmaceutical Group's GHG Emissions Dataset?
Sign Up